Connor, Clark & Lunn Investment Management (CC&L)’s BELLUS Health Inc. BLU Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-738,200	Closed	-$5.3M	–	1568
2023 Q1	$5.3M	Sell	738,200 -368,300	-33%	-$2.86M	0.03%	356
2022 Q4	$9.06M	Buy	1,106,500 +400	+0%	+$3.73K	0.05%	243
2022 Q3	$11.7M	Buy	1,106,100 +220,970	+25%	+$2.35M	0.08%	185
2022 Q2	$8.15M	Buy	885,130 +77,930	+10%	+$637K	0.05%	223
2022 Q1	$5.58M	Buy	807,200 +621,300	+334%	+$4M	0.03%	309
2021 Q4	$1.5M	Buy	+185,900	New	+$1.23M	0.01%	599

Other funds holding BLU

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

VAM

Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s BLU Position: Q2 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 738,200 shares — an estimated $5.3M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BLU in Q4 2021 and held it in 6 quarters. The position peaked at $11.7M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 738,200 BELLUS Health Inc. shares in Q2 2023, an estimated $5.3M.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BELLUS Health Inc. in Q4 2021 and held it in 6 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s BELLUS Health Inc. position peaked at $11.7M in Q3 2022.
11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2023, filed 10 Aug 2023.